Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2020 06:05 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020

Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover...
November 12, 2019 08:35 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

– Following new positive data from Phase 2a study, Company outlines next steps in clinical development plan for lead program CC-31244 for ultrashort treatment of hepatitis C (HepC) – –...
November 12, 2018 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update

BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...
May 11, 2018 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update

ATLANTA, GA and BOTHELL, WA, May 11, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...
December 16, 2015 16:05 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Appoints Dr. Frank Verwiel to Board of Directors

NEW HAVEN, Conn., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the appointment of Frank Verwiel, M.D., former President and Chief Executive...
November 05, 2015 17:51 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Reports Third Quarter And Nine Month 2015 Financial Results

NEW HAVEN, Conn., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and nine months ended September 30, 2015. For the...